Aevitas Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$215K Buy
+1,939
New +$198K 0.13% 110
2019
Q2
Sell
-1,306
Closed -$103K 241
2019
Q1
$103K Sell
1,306
-111
-8% -$8.3K 0.09% 136
2018
Q4
$103K Buy
1,417
+3
+0.2% +$212 0.11% 130
2018
Q3
$96K Buy
1,414
+222
+19% +$14.1K 0.09% 143
2018
Q2
$69K Sell
1,192
-204
-15% -$11.5K 0.07% 162
2018
Q1
$73K Buy
1,396
+122
+10% +$6.59K 0.07% 153
2017
Q4
$68K Buy
+1,274
New +$70.6K 0.06% 168

Other funds holding MRK

Aevitas Wealth Management's MRK Position: Q4 2022 in Review

Aevitas Wealth Management opened a new position in Merck (MRK) in Q4 2022: 1,939 shares worth $215K. The stake represents 0.13% of the portfolio and ranks #110 among its holdings. This is a return to the name: Aevitas Wealth Management previously reported a position in MRK as recently as Q1 2019.

Aevitas Wealth Management first reported a position in MRK in Q4 2017 and has held it in 7 quarters since. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Aevitas Wealth Management held 1,939 shares of Merck worth $215K as of Q4 2022.
  • Merck was a new Aevitas Wealth Management position in Q4 2022.
  • Merck made up 0.13% of Aevitas Wealth Management's portfolio in Q4 2022, its #110 holding.
  • Aevitas Wealth Management first reported a position in Merck in Q4 2017 and has held it in 7 quarters since.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Aevitas Wealth Management's 13F filing for Q4 2022, filed 24 Jan 2023.